Some experimental results showed that Akt was over expressed in the kidney of diabetic rats, and liraglutide could reduce the expression level of Akt1, hinder renal fibrosis, relieve oxidative stress and improve diabetic nephropathy [40]. This evidence concerns the gene AKT1 and diabetic kidney disease.